NINTEDANIB for Lung adenocarcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 793 adverse event reports in the FDA FAERS database where NINTEDANIB was used for Lung adenocarcinoma.
Most Reported Side Effects for NINTEDANIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 9,103 | 34.7% | 1,063 | 3,967 |
| Nausea | 4,198 | 16.0% | 349 | 1,832 |
| Dyspnoea | 3,080 | 11.7% | 500 | 1,692 |
| Decreased appetite | 2,832 | 10.8% | 348 | 1,390 |
| Death | 2,790 | 10.6% | 2,783 | 545 |
| Weight decreased | 2,628 | 10.0% | 309 | 1,278 |
| Vomiting | 2,524 | 9.6% | 238 | 1,183 |
| Fatigue | 2,511 | 9.6% | 261 | 1,094 |
| Cough | 2,193 | 8.4% | 220 | 1,016 |
| Idiopathic pulmonary fibrosis | 1,905 | 7.3% | 960 | 909 |
| Constipation | 1,756 | 6.7% | 144 | 803 |
| Abdominal pain upper | 1,664 | 6.3% | 103 | 751 |
| Asthenia | 1,487 | 5.7% | 178 | 750 |
| Headache | 1,461 | 5.6% | 66 | 577 |
| Abdominal discomfort | 1,418 | 5.4% | 76 | 635 |
Other Indications for NINTEDANIB
Idiopathic pulmonary fibrosis (13,678)
Product used for unknown indication (6,075)
Interstitial lung disease (2,999)
Pulmonary fibrosis (1,539)
Non-small cell lung cancer (580)
Systemic sclerosis pulmonary (214)
Adenocarcinoma (206)
Systemic scleroderma (204)
Lung neoplasm malignant (127)
Hypersensitivity pneumonitis (108)
Other Drugs Used for Lung adenocarcinoma
PEMETREXED (4,280)
PEMBROLIZUMAB (3,954)
CARBOPLATIN (3,888)
BEVACIZUMAB (1,522)
PACLITAXEL (1,216)
NIVOLUMAB (1,162)
ATEZOLIZUMAB (1,032)
CISPLATIN (1,003)
DOCETAXEL (977)
OSIMERTINIB (936)